Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1479144596;44597;44598 chr2:178629354;178629353;178629352chr2:179494081;179494080;179494079
N2AB1315039673;39674;39675 chr2:178629354;178629353;178629352chr2:179494081;179494080;179494079
N2A1222336892;36893;36894 chr2:178629354;178629353;178629352chr2:179494081;179494080;179494079
N2B572617401;17402;17403 chr2:178629354;178629353;178629352chr2:179494081;179494080;179494079
Novex-1585117776;17777;17778 chr2:178629354;178629353;178629352chr2:179494081;179494080;179494079
Novex-2591817977;17978;17979 chr2:178629354;178629353;178629352chr2:179494081;179494080;179494079
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: D
  • RefSeq wild type transcript codon: GAT
  • RefSeq wild type template codon: CTA
  • Domain: Ig-99
  • Domain position: 27
  • Structural Position: 43
  • Q(SASA): 0.8158
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
D/E rs772552324 0.106 0.946 N 0.475 0.226 0.294918367191 gnomAD-2.1.1 4.03E-06 None None None None N None 0 0 None 0 0 None 3.27E-05 None 0 0 0
D/E rs772552324 0.106 0.946 N 0.475 0.226 0.294918367191 gnomAD-4.0.0 6.84602E-07 None None None None N None 0 0 None 0 0 None 0 0 0 1.15972E-05 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
D/A 0.2638 likely_benign 0.2935 benign -0.192 Destabilizing 0.811 D 0.616 neutral D 0.541225595 None None N
D/C 0.8021 likely_pathogenic 0.8157 pathogenic -0.132 Destabilizing 0.999 D 0.7 prob.neutral None None None None N
D/E 0.2779 likely_benign 0.293 benign -0.294 Destabilizing 0.946 D 0.475 neutral N 0.506019939 None None N
D/F 0.7396 likely_pathogenic 0.7563 pathogenic -0.085 Destabilizing 0.996 D 0.655 neutral None None None None N
D/G 0.1292 likely_benign 0.1226 benign -0.383 Destabilizing 0.004 N 0.348 neutral N 0.48065576 None None N
D/H 0.4251 ambiguous 0.4691 ambiguous 0.226 Stabilizing 0.999 D 0.541 neutral D 0.595878374 None None N
D/I 0.5977 likely_pathogenic 0.6535 pathogenic 0.262 Stabilizing 0.996 D 0.662 neutral None None None None N
D/K 0.5666 likely_pathogenic 0.6007 pathogenic 0.223 Stabilizing 0.988 D 0.513 neutral None None None None N
D/L 0.5971 likely_pathogenic 0.6198 pathogenic 0.262 Stabilizing 0.988 D 0.653 neutral None None None None N
D/M 0.7812 likely_pathogenic 0.8003 pathogenic 0.207 Stabilizing 0.999 D 0.69 prob.neutral None None None None N
D/N 0.1178 likely_benign 0.1315 benign -0.04 Destabilizing 0.896 D 0.541 neutral N 0.511986766 None None N
D/P 0.8464 likely_pathogenic 0.863 pathogenic 0.132 Stabilizing 0.996 D 0.545 neutral None None None None N
D/Q 0.5403 ambiguous 0.5679 pathogenic -0.001 Destabilizing 0.996 D 0.495 neutral None None None None N
D/R 0.6036 likely_pathogenic 0.6346 pathogenic 0.487 Stabilizing 0.988 D 0.63 neutral None None None None N
D/S 0.2176 likely_benign 0.2349 benign -0.167 Destabilizing 0.919 D 0.506 neutral None None None None N
D/T 0.3979 ambiguous 0.4404 ambiguous -0.016 Destabilizing 0.988 D 0.513 neutral None None None None N
D/V 0.399 ambiguous 0.4516 ambiguous 0.132 Stabilizing 0.984 D 0.653 neutral D 0.563998598 None None N
D/W 0.9276 likely_pathogenic 0.9357 pathogenic 0.039 Stabilizing 0.999 D 0.707 prob.neutral None None None None N
D/Y 0.2976 likely_benign 0.3296 benign 0.153 Stabilizing 0.995 D 0.659 neutral D 0.661053303 None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.